Zentalis Pharmaceuticals
ZNTL
ZNTL
95 hedge funds and large institutions have $1.58B invested in Zentalis Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $1.94B → $1.58B (-$361M)
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
Holders
95
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$27.1M | |
| 2 | +$25.1M | |
| 3 | +$11.8M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$9.76M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$5.57M |
Top Sellers
| 1 | -$54.5M | |
| 2 | -$26.6M | |
| 3 | -$20.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$19.5M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$8.48M |